- Home
- FMST vs EDSA Comparison
FMST vs EDSA Comparison
Compare FMST & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- EDSA
- Stock Information
- Founded
- FMST 2005
- EDSA 2015
- Country
- FMST Canada
- EDSA Canada
- Employees
- FMST N/A
- EDSA N/A
- Industry
- FMST Other Metals and Minerals
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- EDSA Health Care
- Exchange
- FMST Nasdaq
- EDSA Nasdaq
- Market Cap
- FMST 39.6M
- EDSA 13.8M
- IPO Year
- FMST N/A
- EDSA N/A
- Fundamental
- Price
- FMST $3.15
- EDSA $2.07
- Analyst Decision
- FMST
- EDSA Strong Buy
- Analyst Count
- FMST 0
- EDSA 2
- Target Price
- FMST N/A
- EDSA $13.00
- AVG Volume (30 Days)
- FMST 630.4K
- EDSA 14.5K
- Earning Date
- FMST 01-01-0001
- EDSA 08-08-2025
- Dividend Yield
- FMST N/A
- EDSA N/A
- EPS Growth
- FMST N/A
- EDSA N/A
- EPS
- FMST N/A
- EDSA N/A
- Revenue
- FMST N/A
- EDSA N/A
- Revenue This Year
- FMST N/A
- EDSA N/A
- Revenue Next Year
- FMST N/A
- EDSA N/A
- P/E Ratio
- FMST N/A
- EDSA N/A
- Revenue Growth
- FMST N/A
- EDSA N/A
- 52 Week Low
- FMST $0.55
- EDSA $1.55
- 52 Week High
- FMST $5.74
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- FMST 47.92
- EDSA 54.22
- Support Level
- FMST $3.02
- EDSA $2.03
- Resistance Level
- FMST $3.38
- EDSA $2.12
- Average True Range (ATR)
- FMST 0.33
- EDSA 0.10
- MACD
- FMST -0.11
- EDSA 0.01
- Stochastic Oscillator
- FMST 24.53
- EDSA 68.97
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.